The Latest Cardiac and Vascular News
SUZHOU, China, June 4, 2021 /PRNewswire/ — Peijia Medical Limited signed a memorandum of strategic cooperation with China Resources Pharmaceutical Commercial Group Medical Devices Co., Ltd. on June 2. Going forward, the two parties will collaborate intensively on the commercialization of TAVR products, ultimately providing more Chinese medical staff and patients with better quality […]
SUZHOU, China, April 24, 2021 /PRNewswire/ — A new interventional solution from China for structural heart disease is about to be launched onto the market. Recently, TaurusOne® Transcatheter Aortic Valve Replacement System (hereinafter referred to as “TaurusOne®“) developed by Peijia Medical (Suzhou) Co., Ltd., located in Suzhou Industrial Park, Jiangsu Province, was officially approved for commercialization […]
Collaboration Strengthens Peijia’s Position for Competing in a Largely Untapped Market and Supports Global Expansion of HighLife’s Technology SUZHOU, China and PARIS, Dec. 20, 2020 /PRNewswire/ — Peijia Medical Ltd (HK Stock Code: 09996) and HighLife SAS, a Paris-based medical device company, focused on the development of a unique transeptal mitral valve replacement (“TMVR”) system to treat […]
